HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determination of the importance of the stereochemistry of psorospermin in topoisomerase II-induced alkylation of DNA and in vitro and in vivo biological activity.

Abstract
Psorospermin is a natural product that has been shown to have activity against drug-resistant leukemia lines and AIDS-related lymphoma. It has also been shown to alkylate DNA through an epoxide-mediated electrophilic attack, and this alkylation is greatly enhanced at specific sites by topoisomerase II. In this article, we describe the synthesis of the two diastereomers of O5-methyl psorospermin and their in vitro activity against a range of solid and hematopoietic tumors. The diastereomeric pair (+/-)-(2'R,3'R) having the naturally occurring enantiomer (2'R,3'R) is the most active across all the cell lines and shows approximately equal activity in both drug-sensitive and drug-resistant cell lines. In subsequent studies using all four enantiomers of O5-methyl psorospermin, the order of biological potency is (2'R,3'R) > (2'R,3'S) = (2'S,3'R) > (2'S,3'S). This order of potency is also found in the topoisomerase II-induced alkylation of O5-methyl psorospermin and can be rationalized by molecular modeling of the psorospermin-duplex binding complex. Therefore, this study defines the optimum stereochemical requirements for both the topoisomerase II-induced alkylation of DNA and the biological activity by psorospermin and its O5-methyl derivatives. Finally, (2'R,3'R) psorospermin was found to be as effective as gemcitabine in slowing tumor growth in vivo in a MiaPaCa pancreatic cancer model. In addition, (2'R,3'R) psorospermin in combination with gemcitabine was found to show an at least additive effect in slowing tumor growth of MiaPaCa.
AuthorsIngrid M Fellows, Michael Schwaebe, Thomas S Dexheimer, Hariprasad Vankayalapati, Mary Gleason-Guzman, Jeffrey P Whitten, Laurence H Hurley
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 4 Issue 11 Pg. 1729-39 (Nov 2005) ISSN: 1535-7163 [Print] United States
PMID16275994 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Epoxy Compounds
  • Xanthones
  • Deoxycytidine
  • psorospermin
  • DNA
  • DNA Topoisomerases, Type II
  • Gemcitabine
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols
  • Body Weight
  • Cell Line
  • Cell Line, Tumor
  • DNA (chemistry)
  • DNA Topoisomerases, Type II (metabolism)
  • Deoxycytidine (administration & dosage, analogs & derivatives, pharmacology)
  • Drug Screening Assays, Antitumor
  • Epoxy Compounds (chemistry)
  • In Vitro Techniques
  • Inhibitory Concentration 50
  • Leukemia (drug therapy)
  • Lymphoma (drug therapy)
  • Mice
  • Mice, Nude
  • Models, Chemical
  • Models, Molecular
  • Pancreatic Neoplasms (drug therapy, enzymology, pathology)
  • Stereoisomerism
  • Time Factors
  • Xanthones (administration & dosage, chemical synthesis, chemistry)
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: